Burlington, Ontario–(Newsfile Corp. – October 2, 2025) – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“ RDT ” or the “ Company “) announced today that as contemplated in the secured convertible notes (the “ Notes “) previously issued on its private placement financing (the “ Financing “), and consistent with prior quarters, the Company intends to issue common shares (“ Common Shares “) in satisfaction of the accrued interest payable on September 30, 2025 under the terms of the Notes. The Company expects to issue the Common Shares no later than October 15, 2025.

The Financing was an offering of units (the “ Units “) at a price of $1.00 per Unit. Each Unit consisted of $1.00 principal amount of Notes and five common share purchase warrants of the Company (the “ Warrants “). The

See Full Page